These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 11726142)
1. Inhibitory activity of Bifidobacterium longum HY8001 against Vero cytotoxin of Escherichia coli O157:H7. Kim SH; Yang SJ; Koo HC; Bae WK; Kim JY; Park JH; Baek YJ; Park YH J Food Prot; 2001 Nov; 64(11):1667-73. PubMed ID: 11726142 [TBL] [Abstract][Full Text] [Related]
2. Liu D; Li C; Cao T; Lv X; Yue Y; Li S; Cheng Y; Liu F; Huo G; Li B Nutrients; 2024 Apr; 16(8):. PubMed ID: 38674854 [TBL] [Abstract][Full Text] [Related]
3. Prevention of Escherichia coli O157:H7 infection in gnotobiotic mice associated with Bifidobacterium strains. Yoshimura K; Matsui T; Itoh K Antonie Van Leeuwenhoek; 2010 Feb; 97(2):107-17. PubMed ID: 19911297 [TBL] [Abstract][Full Text] [Related]
4. Effect of Bifidobacterium thermacidophilum probiotic feeding on enterohemorrhagic Escherichia coli O157:H7 infection in BALB/c mice. Gagnon M; Kheadr EE; Dabour N; Richard D; Fliss I Int J Food Microbiol; 2006 Aug; 111(1):26-33. PubMed ID: 16822570 [TBL] [Abstract][Full Text] [Related]
5. Oral therapeutic agents with highly clustered globotriose for treatment of Shiga toxigenic Escherichia coli infections. Watanabe M; Matsuoka K; Kita E; Igai K; Higashi N; Miyagawa A; Watanabe T; Yanoshita R; Samejima Y; Terunuma D; Natori Y; Nishikawa K J Infect Dis; 2004 Feb; 189(3):360-8. PubMed ID: 14745692 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of Vero cell cytotoxic activity in Escherichia coli O157:H7 lysates by globotriaosylceramide, Gb3, from bovine milk. Watarai S; Tana ; Inoue K; Kushi Y; Isogai E; Yokota K; Naka K; Oguma K; Kodama H Biosci Biotechnol Biochem; 2001 Feb; 65(2):414-9. PubMed ID: 11302178 [TBL] [Abstract][Full Text] [Related]
7. Selenium reduces enterohemorrhagic Escherichia coli O157:H7 verotoxin production and globotriaosylceramide receptor expression on host cells. Surendran-Nair M; Kollanoor-Johny A; Ananda-Baskaran S; Norris C; Lee JY; Venkitanarayanan K Future Microbiol; 2016 Jun; 11():745-56. PubMed ID: 27191971 [TBL] [Abstract][Full Text] [Related]
9. The effect of probiotics and organic acids on Shiga-toxin 2 gene expression in enterohemorrhagic Escherichia coli O157:H7. Carey CM; Kostrzynska M; Ojha S; Thompson S J Microbiol Methods; 2008 May; 73(2):125-32. PubMed ID: 18328583 [TBL] [Abstract][Full Text] [Related]
10. Shiga toxin mode of action in E. coli O157:H7 disease. Obrig TG Front Biosci; 1997 Dec; 2():d635-42. PubMed ID: 9392626 [TBL] [Abstract][Full Text] [Related]
11. Development of antimicrobial synbiotics using potentially-probiotic faecal isolates of Lactobacillus fermentum and Bifidobacterium longum. Likotrafiti E; Tuohy KM; Gibson GR; Rastall RA Anaerobe; 2013 Apr; 20():5-13. PubMed ID: 23354005 [TBL] [Abstract][Full Text] [Related]
12. Cattle lack vascular receptors for Escherichia coli O157:H7 Shiga toxins. Pruimboom-Brees IM; Morgan TW; Ackermann MR; Nystrom ED; Samuel JE; Cornick NA; Moon HW Proc Natl Acad Sci U S A; 2000 Sep; 97(19):10325-9. PubMed ID: 10973498 [TBL] [Abstract][Full Text] [Related]
13. Essential role for verotoxin in sustained stress-activated protein kinase and nuclear factor kappa B signaling, stimulated by Escherichia coli O157:H7 in Vero cells. Cameron P; Bingham D; Paul A; Pavelka M; Cameron S; Rotondo D; Plevin R Infect Immun; 2002 Oct; 70(10):5370-80. PubMed ID: 12228261 [TBL] [Abstract][Full Text] [Related]
14. Probiotic inhibits the cytopathic effect induced by Escherichia coli O157:H7 in Vero cell line model. Tahamtan Y; Kargar M; Namdar N; Rahimian A; Hayati M; Namavari MM Lett Appl Microbiol; 2011 May; 52(5):527-31. PubMed ID: 21355874 [TBL] [Abstract][Full Text] [Related]
15. The hemorrhagic coli pilus (HCP) of Escherichia coli O157:H7 is an inducer of proinflammatory cytokine secretion in intestinal epithelial cells. Ledesma MA; Ochoa SA; Cruz A; Rocha-Ramírez LM; Mas-Oliva J; Eslava CA; Girón JA; Xicohtencatl-Cortes J PLoS One; 2010 Aug; 5(8):e12127. PubMed ID: 20711431 [TBL] [Abstract][Full Text] [Related]
16. Surface properties of the Vero cytotoxin-producing Escherichia coli O157:H7. Sherman P; Soni R; Petric M; Karmali M Infect Immun; 1987 Aug; 55(8):1824-9. PubMed ID: 2886431 [TBL] [Abstract][Full Text] [Related]
17. Colistin inhibits E. coli O157:H7 Shiga-like toxin release, binds endotoxins and protects Vero cells. Percivalle E; Monzillo V; Pauletto A; Marone P; Imberti R New Microbiol; 2016 Apr; 39(2):119-23. PubMed ID: 27196550 [TBL] [Abstract][Full Text] [Related]
18. Pathogenic mechanism of mouse brain damage caused by oral infection with Shiga toxin-producing Escherichia coli O157:H7. Kita E; Yunou Y; Kurioka T; Harada H; Yoshikawa S; Mikasa K; Higashi N Infect Immun; 2000 Mar; 68(3):1207-14. PubMed ID: 10678928 [TBL] [Abstract][Full Text] [Related]
19. Rapid method to detect shiga toxin and shiga-like toxin I based on binding to globotriosyl ceramide (Gb3), their natural receptor. Ashkenazi S; Cleary TG J Clin Microbiol; 1989 Jun; 27(6):1145-50. PubMed ID: 2666433 [TBL] [Abstract][Full Text] [Related]
20. Targeted disruption of Gb3/CD77 synthase gene resulted in the complete deletion of globo-series glycosphingolipids and loss of sensitivity to verotoxins. Okuda T; Tokuda N; Numata S; Ito M; Ohta M; Kawamura K; Wiels J; Urano T; Tajima O; Furukawa K; Furukawa K J Biol Chem; 2006 Apr; 281(15):10230-5. PubMed ID: 16476743 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]